HAMP and chronic kidney disease: However, the predictive value of diagnosing FID among late stage CKD disease using hepcidin as a biomarker was about 75.2%, while there was no statistically significant association between hepcidin and FID among patients with early stage CKD; (Supplementary Table 5).